HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction.

PLoS One · 2016 · PMC4999185 · PMID 27559738

Europe PMC DOI

hedged sentence

0.1870

closest p · 3.7× alpha

0.1870

boldest claim

The sentences

a nonsignificant trendp = 0.187not close (p > 0.1)

There was a nonsignificant trend toward increased overexpression of HER2 in HGD lesions (5.3% vs. 0.0%, p = 0.187) ( Fig 2 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.